Using the large annotated multi-tumor cancer genome sequencing resource, we identified 41 mutations (31 residues in the CH-domain and 10 residues at the ATP-binding site) across the coding region of the core component of the NMD pathway, UPF1 (Figure 1C, Figure 2, and Figure S2). This evidence concerns the gene UPF1 and neoplasm.